Mike M. Goldberg
Chief Executive Officer chez Macrophage Therapeutics, Inc.
Profil
Dr. Mike M.
Goldberg, MD MBA, is Chairman at Urigen Pharmaceuticals, Inc., Independent Director at Echo Therapeutics, Inc., and Managing Partner at Montaur Capital Partners LLC.
He is on the Board of Directors at Echo Therapeutics, Inc., Navidea Biopharmaceuticals, Inc., CorNova, Inc., and Angiolight, Inc.
Dr. Goldberg was previously employed as Independent Director by Alliqua, Inc., Independent Director by Mast Therapeutics, Inc., Chairman & Chief Executive Officer by Emisphere Technologies, Inc., and VP & Founding Member-Healthcare Banking Group by First Boston Corp.
He also served on the board at HepaLife Technologies, Inc.
He received his undergraduate degree from Rensselaer Polytechnic Institute, an MBA from Columbia Business School, and a doctorate degree from Albany Medical College.
Postes actifs de Mike M. Goldberg
| Sociétés | Poste | Début |
|---|---|---|
Montaur Capital Partners LLC
 Montaur Capital Partners LLC Investment ManagersFinance Montaur Capital Partners LLC is a private equity firm located in New York City. The firm manages the Platinum Montaur Life Sciences Fund. | Chief Investment Officer | 03/11/2010 |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Chairman | 01/02/2015 |
CorNova, Inc.
 CorNova, Inc. Medical SpecialtiesHealth Technology CorNova, Inc. develops medical devices. It product, FiberHalo SRM Stent Deployment Catheter, enables the physician to deploy a stent and measure in-stent lumen area during the angioplasty procedure. The company was founded by S. Eric Ryan in 2003 and is headquartered in Burlington, MA. | Director/Board Member | - |
LifeSci Advisors LLC
 LifeSci Advisors LLC Miscellaneous Commercial ServicesCommercial Services LifeSci Advisors LLC is an investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. Their services are designed to increase clients? visibility within the investment community and to educate investors about the opportunity. | Corporate Officer/Principal | - |
Macrophage Therapeutics, Inc.
 Macrophage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. develops immune-oncology and anti-inflammatory therapeutics. The CEO of the American company is Mike M. Goldberg. | Chief Executive Officer | - |
Anciens postes connus de Mike M. Goldberg
| Sociétés | Poste | Fin |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Chief Executive Officer | 14/08/2018 |
| ECHO THERAPEUTICS, INC. | Chairman | 21/03/2017 |
Alliqua BioMedical, Inc.
 Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Director/Board Member | 15/05/2012 |
HepaLife Technologies, Inc.
 HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Director/Board Member | 06/01/2011 |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Mike M. Goldberg
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| Albany Medical College | Doctorate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
| First Boston Corp. | Finance |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
ThinkEquity Partners
 ThinkEquity Partners Investment ManagersFinance Headquartered in San Francisco with additional offices in New York City, Minneapolis, Chicago and Boston, ThinkEquity Partners is a broker/dealer. The firm offers targeted research and investment banking services for institutional investors and corporate clients. They specialize in identifying, analyzing and understanding the technological, macroeconomic and cultural trends that impact key growth verticals, with a particular concentration on healthcare, technology, media/education and business/consumer services. The firm starts with a top-down analysis approach and then allocates resources based on a long-range research roadmap. | Finance |
CorNova, Inc.
CorNova, Inc. Medical SpecialtiesHealth Technology CorNova, Inc. develops medical devices. It product, FiberHalo SRM Stent Deployment Catheter, enables the physician to deploy a stent and measure in-stent lumen area during the angioplasty procedure. The company was founded by S. Eric Ryan in 2003 and is headquartered in Burlington, MA. | Health Technology |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Health Technology |
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
Montaur Capital Partners LLC
Montaur Capital Partners LLC Investment ManagersFinance Montaur Capital Partners LLC is a private equity firm located in New York City. The firm manages the Platinum Montaur Life Sciences Fund. | Finance |
LifeSci Advisors LLC
LifeSci Advisors LLC Miscellaneous Commercial ServicesCommercial Services LifeSci Advisors LLC is an investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. Their services are designed to increase clients? visibility within the investment community and to educate investors about the opportunity. | Commercial Services |
Macrophage Therapeutics, Inc.
Macrophage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. develops immune-oncology and anti-inflammatory therapeutics. The CEO of the American company is Mike M. Goldberg. | Commercial Services |
| Angiolight, Inc. | |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
